On March 1, 2021 IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, reported its participation at the following upcoming investor relations events (Press release, Ideaya Biosciences, MAR 1, 2021, View Source [SID1234575882]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investor Relations Events

H.C. Wainwright Global Life Sciences Conference 2021 (Virtual)
Corporate Presentation
Tuesday, March 9th, 2021 at 7:00 am ET
Citi’s 2021 Winter West Coast Biotech Virtual Bus Tour (Virtual)
Fireside Chat with Analyst Mohit Bansal
Tuesday, March 16th, 2021 at 3:00 pm ET
Oppenheimer’s 31st Annual Healthcare Conference (Virtual)
Company Presentation
Wednesday, March 17th, 2021 at 2:30 pm ET
Roth 33rd Annual Conference (Virtual)
Company Panel hosted by Analyst Zegbeh Jallah: "Highly Attractive Small Molecule
Oncology Platforms" with Arvinas, IDEAYA Biosciences and Turning Point Therapeutics
Wednesday, March 17th, 2021 at 5:00 pm ET
A live audio webcast of selected events will be available by visiting the "Investors/News and Events/Investor Calendar" section of the IDEAYA website at View Source A replay of selected webcasts will be available for 30 days following the live event.